We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Diagnostics

Image: Visual Abstract (Seemesh Bhaskar et al., Point of care molecular cancer diagnostics, Lab on a Chip, 2026. DOI: 10.1039/d5lc01014d)

Point-of-Care Molecular Technology Promises Transformative Shift in Oncology

A new review highlights how POC molecular diagnostic technology is transforming cancer detection and treatment monitoring. More...
23 Jul 2026
Image: FirstGene delivers fetal chromosome, fetal single-gene, patient carrier, and fetal RhD screening in one integrated report (Photo courtesy of Myriad Genetics)

New Test Delivers Four Prenatal Genetic Screens from One Blood Sample

Myriad Genetics has launched FirstGene, a single-sample prenatal test that performs four genetic screens simultaneously. More...
22 Jul 2026
Image: The assay is designed to concurrently detect HSV-1, HSV-2, VZV, and MPXV in a single test (Image Credit: Adobe Stock)

Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions

Seegene USA’s Allplex HSV-1&2/VZV/MPXV Assay has received Emergency Use Authorization (EUA) from the U.S. FDA. More...
21 Jul 2026
Graphical Abstract: Changes in circulating tumor DNA during Ra-223 treatment reflect disease course in patients with bone-metastatic castration-resistant prostate cancer. (Image created by Masaki Shiota et al., Kyushu University, Fukuoka, Japan)

Blood Test Guides Patient Selection for Radiopharmaceutical Therapy in Prostate Cancer

A new blood-based tumor DNA test predicts which patients benefit from radium-223 and tracks response to guide treatment in real time. More...
21 Jul 2026
Image Credit: Shutterstock

New Biomarker Helps Guide Combination Therapy for Treatment-Resistant Breast Cancer

New findings identify a biomarker of chemotherapy-resistant triple-negative breast cancer, helping guide targeted combination therapy. More...
20 Jul 2026
Image: Early-stage pancreatic cancer detection by a blood test. oward the development of a diagnostic system for early-stage pancreatic cancer: A non-invasive, blood-based gene expression test enables the detection of Stage 0 pancreatic cancer (5-year survival rate: 100% at Kanazawa University Hospital) and StageⅠdisease (5-year survival rate: 74.4%). (Photo courtesy of Kanazawa University)

Blood-Based Gene Expression Test Detects Early Pancreatic Cancer

A new noninvasive whole-blood gene expression test detects most stage 0-I pancreatic cancers. More...
20 Jul 2026
Image: Global genetic spectrum of Parkinson\'s disease and locations of clinical trials targeting gene variant carriers (Lara M Lange et al., The Lancet Neurology (2026). DOI: 10.1016/s1474-4422(26)00198-5)

Global Genetic Map Identifies Regional Parkinson’s Variants to Support Diagnostics

New data map global Parkinson's GBA1 and LRRK2 variants, revealing regional differences to improve diagnostics and trial design More...
18 Jul 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Neonatal Heel Incision Device
Tenderfoot


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.